This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.
Original paper

A Systems Pharmacology Approach Uncovers Wogonoside as an Angiogenesis Inhibitor of Triple-Negative Breast Cancer by Targeting Hedgehog Signaling

Volume: 26, Issue: 8, Pages: 1143 - 1158.e6
Published: Jun 6, 2019
Abstract
Highlights•A systems pharmacology approach uncovers wogonoside as a TNBC angiogenesis inhibitor•Network analysis identifies that wogonoside inhibits VEGF expression in TNBC•Wogonoside inhibits the Gli1 nuclear translocation and transcription activities•Wogonoside promotes Smoothened (SMO) degradation in a proteasome-dependent mechanismSummaryTriple-negative breast cancer (TNBC) is an aggressive and heterogeneous disease that lacks clinically...
Paper Details
Title
A Systems Pharmacology Approach Uncovers Wogonoside as an Angiogenesis Inhibitor of Triple-Negative Breast Cancer by Targeting Hedgehog Signaling
Published Date
Jun 6, 2019
Volume
26
Issue
8
Pages
1143 - 1158.e6
© 2025 Pluto Labs All rights reserved.
Step 1. Scroll down for details & analytics related to the paper.
Discover a range of citation analytics, paper references, a list of cited papers, and more.